Health
Aprotinin inhibits SARS-CoV-2 entry and replication in cells cultures – News-Medical.Net
Researchers at the University of Kent in the UK and the Hannover Medical School and Goethe University in Germany have observed that the protease inhibitor aprotinin…
Finding a potential therapeutic target to battle the coronavirus disease 2019 (COVID-19) pandemic is crucial. Caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus has now spread to 191 countries worldwide and has infected over 59.17 million people.
Researchers at the University of Kent in the UK and the Hannover Medical School and Goethe University in Germany have observed that the protease inhibitor aprotinin can inhibit viral replication by preventing SARS-CoV-2…
-
General17 hours agoAustralian celebrity chef Peter Russell-Clarke dies aged 89
-
Noosa News17 hours agoWoman airlifted to Brisbane hospital after big cat mauling at south-east Queensland zoo near Toowoomba
-
Business23 hours agoInvested $10,000 in Westpac shares 2 years ago? Guess how much you’ve already banked!
-
Noosa News16 hours agoUnvaccinated horse dies from Hendra virus as Queensland records first case in three years